Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase1/phase2,Single-arm, Open-label Study of RD14-01 in Patients With Advanced Solid Tumors

NCT05748938 is registered in ClinicalTrials.gov with 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05748938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase1/phase2,Single-arm, Open-label Study of RD14-01 in Patients With Advanced Solid Tumors
Lead sponsor
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 8, 2023
Completion date
February 8, 2025
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor